Hagerstown, MDNCT05003310Now EnrollingIRB Ready

Rheumatoid Arthritis Clinical Trial in Hagerstown, MD

Access cutting-edge rheumatoid arthritis treatment through this clinical trial at a research site in Hagerstown. Study-provided care at no cost to qualified participants.

Sponsored by Galvani Bioelectronics

Quick Self-Assessment

See if you qualify for this Hagerstown location

Preparing your pre-screening questions…

Expert Care in Hagerstown

Access rheumatoid arthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rheumatoid arthritis treatment provided free

Apply for This Hagerstown Location

Check if you qualify for this rheumatoid arthritis clinical trial in Hagerstown, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hagerstown

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hagerstown site if eligible
  4. 4Begin participation

About This Rheumatoid Arthritis Study in Hagerstown

This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized Control Trial period (Period 1), an Open Label period (Period 2), a Treat-to-target period (Period 3), and a Long-term Follow-up period (Period 4). Participants eligible for implant will have active rheumatoid arthritis (RA) and have an inadequate response or intolerance to at least two biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) or JAK inhibitors (JAKis). A sufficient number of participants will be enrolled so that approximately 28 participants will undergo device implantation.

Sponsor: Galvani Bioelectronics

Who Can Participate

Inclusion Criteria

RA of at least six months duration, per 2010 ACR/EULAR criteria
Male or female participants, 22-75 years of age
Inadequate Response to at least 2 biologic DMARDs and/or JAK-inhibitors (JAKis) including at least one TNF inhibitor
Have an appropriate washout from previously used biological DMARDs or JAKi
Receiving current treatment with standard dose(s) of conventional synthetic DMARD(s) or have documented history of failure due to ineffectiveness or intolerance

Exclusion Criteria

Inability to provide informed consent
Significant psychiatric disease or substance abuse
History of unilateral or bilateral vagotomy
Active or latent tuberculosis
Known infection with human immunodeficiency virus (HIV); current acute or chronic hepatitis B or hepatitis C; previous hepatitis B
Positive SARS COV 2 PCR screening test for COVID-19 infection (at the point of screening for this study)
Currently implanted electrically active medical devices (e.g., cardiac pacemakers, automatic implantable cardioverter-defibrillators)
Previous splenectomy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hagerstown?

Yes, this clinical trial (NCT05003310) has an active research site in Hagerstown, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Rheumatoid Arthritis Treatment Options in Hagerstown, MD

If you're searching for rheumatoid arthritis treatment options in Hagerstown, MD, this clinical trial (NCT05003310) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hagerstown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rheumatoid arthritis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Hagerstown, MD

See all rheumatoid arthritis clinical trials recruiting in Hagerstown — not just this study.

Browse Rheumatoid Arthritis Trials in Hagerstown

Ready to Join in Hagerstown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hagerstown, MD